SAR.L实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:47):

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases...

Stats
今日成交量	9.55M
平均成交量	1.38M
市值	24.63M
EPS	£0 ( 2024-03-27 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-4.04
ATR14	£0.358 (1.48%)

音量相关性

長: -0.11 (neutral)

短: -0.73 (moderate negative)

Signal:(46.269) Neutral

Sareum Holdings PLC 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sareum Holdings PLC 相关性 - 货币/商品

-0.22
( neutral )

0.35
( neutral )

-0.67
( moderate negative )

0.45
( neutral )

-0.49
( neutral )

0.58
( weak )

Sareum Holdings PLC 财务报表

Annual	2022
营收:	£0
毛利润:	£-1 000.00 (0.00 %)
EPS:	£-0.0469

FY	2022
营收:	£0
毛利润:	£-1 000.00 (0.00 %)
EPS:	£-0.0469

FY	2022
营收:	£0
毛利润:	£0 (0.00 %)
EPS:	£-0.0321

FY	2021
营收:	£0.00
毛利润:	£0.00 (0.00 %)
EPS:	£-0.0265

Financial Reports:

No articles found.

Sareum Holdings PLC

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.